Cipla acquires two US drug firms for $550 mn
Mumbai, Feb 18 (IANS) Drug major Cipla has acquired two US-based firms — InvaGen Pharmaceuticals and Exelan Pharmaceuticals — for $550 million, the company said in a regulatory filing here on Thursday. “The acquisition was…